e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Cystic fibrosis in paediatric patients: current research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Newborn screening for Cystic Fibrosis over 20 years and the identification of affected not detected infants.
I. Doull (Cardiff, United Kingdom), R. Hanks (Cardiff, United Kingdom), C. Course (Cardiff, United Kingdom), S. Moat (Cardiff, United Kingdom)
Source:
International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Session:
Cystic fibrosis in paediatric patients: current research
Session type:
Thematic Poster
Number:
4629
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Doull (Cardiff, United Kingdom), R. Hanks (Cardiff, United Kingdom), C. Course (Cardiff, United Kingdom), S. Moat (Cardiff, United Kingdom). Newborn screening for Cystic Fibrosis over 20 years and the identification of affected not detected infants.. 4629
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Open label case-control study to assess Pidotimod efficacy in Non CF Bronchiectasis Disease: a pilot study
Related content which might interest you:
Newborn Screening for Cystic Fibrosis in Wales over 20 years. Changes in incidence dependent on screening protocol
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Stable lung function is maintained over 2 years in newborn screened (NBS) CF infants
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Newborn screening for cystic fibrosis in Spain
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Respiratory rate in infants with Cystic Fibrosis and healthy controls throughout the first year of life.
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015
Within-subject variability of lung function in newborn screened (NBS) CF infants
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Microbiological yield of oropharyngeal swab compared to induced sputum in children with cystic fibrosis (CF) < 5 years of age
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
Newborn screening in Europe
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Lung clearance index in young children with atypical CF
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Ventilation distribution is not influenced by structural lung disease in infants with cystic fibrosis (CF) diagnosed following newborn screening (NBS)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009
Screening colonoscopy in adults with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Risk factors for early lung function decline in young children with Cystic Fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Is lung function diminished by 3 months of age in infants with cystic fibrosis (CF) diagnosed by newborn screening (NBS)?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010
Normal lung function in infants with cystic fibrosis shortly after birth
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013
Changes in the Lung Clearance Index outside 15% are clinically relevant in children with cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Cystic fibrosis newborn screening for R117H in England
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Lung function at the age of 35 years in individuals with alpha-1-antitrypsin deficiency identified by neonatal screening
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010
Evaluation of the pulmonary function of patients with cystic fibrosis aged 3-18 year old by using impulse oscillometry and spirometry
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015
Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept